From Nasdaq: 2025-03-21 18:15:00

Zoetis (ZTS) closed at $163.03, -0.08% from previous session, trailing S&P 500. Shares up 3.65% in last month, outperforming Medical sector and S&P 500. Expecting EPS of $1.41 and revenue of $2.19 billion in upcoming earnings report. Recent analyst estimates show Zacks Rank of #4 (Sell).

Zoetis currently trades at a Forward P/E ratio of 26.68, premium to industry average. PEG ratio at 2.86, higher than industry average of 0.99. Medical – Drugs industry in top 33% of over 250 industries. Zacks Industry Rank of 82. Top 50% industries outperform bottom half by 2 to 1. Watch stock metrics on Zacks.com.

Get 30-day access to Zacks’ picks for $1, no obligation. Explore portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators. Thousands took advantage. See all Zacks’ buys and sells for $1. Download 7 Best Stocks for Next 30 Days for free. Visit Zacks.com for more information.



Read more at Nasdaq: Zoetis (ZTS) Stock Declines While Market Improves: Some Information for Investors